Case Study:
Using AI in Precision Identification of Patients With Rare Diseases
AI-Powered Rare Disease Patient Identification and Diagnosis
Rare diseases offer diverse challenges. With Pharma offering rare disease medication, if you can find the patient, they will take your drug; however, finding the patient is the tricky part.
The Client Problem
The client had a rare disease drug with minimal competition.
• The illness is so rare, however, that the main difficulty was finding patients.
• Very few physicians were likely to come in contact with these patients.
• Finding these patients early is critical as the illness progresses.
The Solution
• Certain facial traits were common to sufferers of the condition.
• Eularis created facial recognition software that identified patients with the condition
• It then crawled internet properties, (Facebook and Flickr etc), to find patients from online photos
• This allowed for faster identification and treatment before it was too late for these patients.
• However, due to sensitivity, the identification was addressed in a more palatable way.
• Once patients were identified, targeted advertising of keywords on Google PPC was prepared.
• Therefore, only when a search was conducted on the symptoms by the family, would this be activiated
• This triggered an ad leading them to our client’s website where they could self diagnose
The Outcome
Thirteen new patients were identified very rapidly. At a cost of $500,000/patient/year for the rest of their life, the ROI is undeniable.
To achieve these kinds of results, contact Eularis today.
Latest News
Read our latest blogs here.
How to Spot and Prevent Deepfakes Spreading Medical Misinformation
Back in 2021, many people died and the US economy suffered losses worth $50-300 million each day – both from people refusing to get COVID-19
Multi-Agent Systems: The Limitless Potential of AI Agents in Healthcare and Pharma
Imagine a hospital where all the computer systems can talk to each other seamlessly, schedule appointments, and keep track of medical records without human intervention.
FDA Approved AI: Where Are We Today?
The U.S. Food and Drug Administration regulates certain AI/machine learning-based medical devices through its premarket review and approval pathways. Any software or device that utilizes